Loncastuximab in High-Risk and Heavily-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real World Analysis from 21 US Centers

Emily C. Ayers, Narendranath Epperla, Debamita Kundu et al.|Blood|2023

Cited by 10